CLINICAL_TRIALS
research
· 2022-01-28
Clinical Trial Update: Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease [Phase 4]
Summary
A Phase 4 trial evaluating how chronic kidney disease affects the effects of ticagrelor in patients with diabetes and coronary artery disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Florida | Conditions: Coronary Artery Disease, Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2022-01-28